Our work now provides a detailed characterization of minimal epitopes derived from the complete SARS-CoV-2 genome for their CD8+ T cell immunogenicity, immunodominance, and functional and phenotypical characteristics in COVID-19 patients and healthy donors. This evidence concerns the gene CD8A and COVID-19.